10-Q Filing

DocGo Inc. CIK: 1822359 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-070146`
Period End Date	20220930
Filing Date	20221108
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	f10q0922_docgoinc_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 112 Cash Flow Statement 101 Stockholders Equity 62

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$7.38M	USD	Point-in-time
Accounts receivable, net of allowance (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$7.38M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$175.54M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$169.60M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Accounts receivable, net of allowance of $7,376,957 and $7,377,389 as of September 30, 2022 and December 31, 2021, respectively	`ReceivablesNetCurrent`	$78.38M	USD	Point-in-time
Accounts receivable, net of allowance of $7,376,957 and $7,377,389 as of September 30, 2022 and December 31, 2021, respectively	`ReceivablesNetCurrent`	$80.00M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.39M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	100.13M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.11M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	102.82M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	102.82M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$251.99M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$256.03M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	100.13M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$17.58M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.73M	USD	Point-in-time
Intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$20.65M	USD	Point-in-time
Intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$10.68M	USD	Point-in-time
Goodwill	`Goodwill`	$34.53M	USD	Point-in-time
Goodwill	`Goodwill`	$8.69M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$3.57M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$9.75M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$8.19M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$4.20M	USD	Point-in-time
Finance lease right-of-use assets	`FinanceLeaseRightOfUseAsset`	$9.31M	USD	Point-in-time
Finance lease right-of-use assets	`FinanceLeaseRightOfUseAsset`	$9.42M	USD	Point-in-time
Equity method investment	`EquityMethodInvestments`	$589.06K	USD	Point-in-time
Equity method investment	`EquityMethodInvestments`	$712.72K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.10M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.81M	USD	Point-in-time
Total assets	`Assets`	$355.92M	USD	Point-in-time
Total assets	`Assets`	$309.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$15.83M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.15M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$38.56M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$35.11M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$1.03M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$25.88K	USD	Point-in-time
Notes payable, current	`NotesPayableCurrent`	$680.70K	USD	Point-in-time
Notes payable, current	`NotesPayableCurrent`	$600.45K	USD	Point-in-time
Due to seller	`DueToRelatedPartiesCurrent`	$9.80M	USD	Point-in-time
Due to seller	`DueToRelatedPartiesCurrent`	$1.57M	USD	Point-in-time
Contingent consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$4.00M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$2.06M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$1.46M	USD	Point-in-time
Finance lease liability, current	`FinanceLeaseLiabilityCurrent`	$2.86M	USD	Point-in-time
Finance lease liability, current	`FinanceLeaseLiabilityCurrent`	$3.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$71.14M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$57.88M	USD	Point-in-time
Notes payable, non-current	`ConvertibleLongTermNotesPayable`	$1.46M	USD	Point-in-time
Notes payable, non-current	`ConvertibleLongTermNotesPayable`	$1.30M	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	$2.98M	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	$6.41M	USD	Point-in-time
Finance lease liability, non-current	`FinanceLeaseLiabilityNoncurrent`	$6.87M	USD	Point-in-time
Finance lease liability, non-current	`FinanceLeaseLiabilityNoncurrent`	$6.09M	USD	Point-in-time
Warrant liabilities	`DerivativeLiabilities`	$13.52M	USD	Point-in-time
Total liabilities	`Liabilities`	$82.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$85.09M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock ($0.0001 par value; 500,000,000 shares authorized as of September 30, 2022 and December 31,2021; 102,824,878 and 100,133,953 shares issued and outstanding as of September 30, 2022 and December 31,2021, respectively	`CommonStockValue`	$10.01K	USD	Point-in-time
Common stock ($0.0001 par value; 500,000,000 shares authorized as of September 30, 2022 and December 31,2021; 102,824,878 and 100,133,953 shares issued and outstanding as of September 30, 2022 and December 31,2021, respectively	`CommonStockValue`	$10.78K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$301.52M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$283.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-63.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-37.04M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-276.21K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-32.50K	USD	Point-in-time
Total stockholders equity attributable to DocGo Inc. and Subsidiaries	`StockholdersEquity`	$219.58M	USD	Point-in-time
Total stockholders equity attributable to DocGo Inc. and Subsidiaries	`StockholdersEquity`	$264.22M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$7.48M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$6.61M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$240.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$270.83M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$254.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.25M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$67.06M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.69M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.95M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$227.06M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$355.92M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$309.60M	USD	Point-in-time

Income Statement 112 line items

Line Item	Tag	Value	Unit	Period
Revenue, net	`Revenues`	$85.84M	USD	1 Quarter
Revenue, net	`Revenues`	$104.32M	USD	1 Quarter
Revenue, net	`Revenues`	$197.39M	USD	3 Qtrs
Revenue, net	`Revenues`	$331.73M	USD	3 Qtrs
Cost of revenues (exclusive of depreciation and amortization, which is shown separately below)	`CostOfRevenues`	$219.42M	USD	3 Qtrs
Cost of revenues (exclusive of depreciation and amortization, which is shown separately below)	`CostOfRevenues`	$71.25M	USD	1 Quarter
Cost of revenues (exclusive of depreciation and amortization, which is shown separately below)	`CostOfRevenues`	$60.03M	USD	1 Quarter
Cost of revenues (exclusive of depreciation and amortization, which is shown separately below)	`CostOfRevenues`	$137.08M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$70.68M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$22.19M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$47.24M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$19.61M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.02M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$7.25M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.51M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.01M	USD	1 Quarter
Legal and regulatory	`LegalFees`	$2.65M	USD	3 Qtrs
Legal and regulatory	`LegalFees`	$813.20K	USD	1 Quarter
Legal and regulatory	`LegalFees`	$2.20M	USD	1 Quarter
Legal and regulatory	`LegalFees`	$6.61M	USD	3 Qtrs
Technology and development	`ResearchAndDevelopmentExpense`	$854.62K	USD	1 Quarter
Technology and development	`ResearchAndDevelopmentExpense`	$3.66M	USD	3 Qtrs
Technology and development	`ResearchAndDevelopmentExpense`	$1.37M	USD	1 Quarter
Technology and development	`ResearchAndDevelopmentExpense`	$1.98M	USD	3 Qtrs
Sales, advertising and marketing	`SellingAndMarketingExpense`	$3.03M	USD	3 Qtrs
Sales, advertising and marketing	`SellingAndMarketingExpense`	$90.86K	USD	1 Quarter
Sales, advertising and marketing	`SellingAndMarketingExpense`	$2.35M	USD	3 Qtrs
Sales, advertising and marketing	`SellingAndMarketingExpense`	$994.40K	USD	1 Quarter
Total expenses	`OperatingExpenses`	$84.32M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$197.49M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$100.12M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$309.98M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-95.98K	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$4.20M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$21.75M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$1.52M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-500.85K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$296.89K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-255.71K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$334.22K	USD	1 Quarter
Gain/(loss) on remeasurement of warrant liabilities	`UnrealizedGainLossOnDerivativesAndCommodityContracts`	-	USD	3 Qtrs
Gain/(loss) on remeasurement of warrant liabilities	`UnrealizedGainLossOnDerivativesAndCommodityContracts`	$-1.83M	USD	1 Quarter
Gain/(loss) on remeasurement of warrant liabilities	`UnrealizedGainLossOnDerivativesAndCommodityContracts`	-	USD	1 Quarter
Gain/(loss) on remeasurement of warrant liabilities	`UnrealizedGainLossOnDerivativesAndCommodityContracts`	$1.14M	USD	3 Qtrs
Gain on initial equity method investments	`IncomeLossFromEquityMethodsInvestments`	-	USD	3 Qtrs
Gain on initial equity method investments	`IncomeLossFromEquityMethodsInvestments`	$99.84K	USD	3 Qtrs
Gain on initial equity method investments	`IncomeLossFromEquityMethodsInvestments`	$93.37K	USD	1 Quarter
Gain on initial equity method investments	`IncomeLossFromEquityMethodsInvestments`	-	USD	1 Quarter
Gain on remeasurement of finance leases	`GainLossOnInvestments`	$1.39M	USD	3 Qtrs
Gain on remeasurement of finance leases	`GainLossOnInvestments`	-	USD	3 Qtrs
Gain on remeasurement of finance leases	`GainLossOnInvestments`	-	USD	1 Quarter
Gain on remeasurement of finance leases	`GainLossOnInvestments`	-	USD	1 Quarter
Gain from PPP loan forgiveness	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Gain from PPP loan forgiveness	`GainsLossesOnExtinguishmentOfDebt`	$142.67K	USD	3 Qtrs
Gain from PPP loan forgiveness	`GainsLossesOnExtinguishmentOfDebt`	$142.67K	USD	1 Quarter
Gain from PPP loan forgiveness	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Gain/(loss) on disposal of fixed assets	`GainLossOnDispositionOfAssets1`	$-27.73K	USD	3 Qtrs
Gain/(loss) on disposal of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Gain/(loss) on disposal of fixed assets	`GainLossOnDispositionOfAssets1`	$42.67K	USD	3 Qtrs
Gain/(loss) on disposal of fixed assets	`GainLossOnDispositionOfAssets1`	$42.67K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$30.90K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$42.29K	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	-	USD	3 Qtrs
Total other (expense) income	`OtherOperatingIncomeExpenseNet`	$-1.33M	USD	1 Quarter
Total other (expense) income	`OtherOperatingIncomeExpenseNet`	$-113.04K	USD	1 Quarter
Total other (expense) income	`OtherOperatingIncomeExpenseNet`	$3.01M	USD	3 Qtrs
Total other (expense) income	`OtherOperatingIncomeExpenseNet`	$-385.91K	USD	3 Qtrs
Net income (loss) before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.87M	USD	1 Quarter
Net income (loss) before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-481.90K	USD	3 Qtrs
Net income (loss) before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$24.76M	USD	3 Qtrs
Net income (loss) before income tax benefit (expense)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.41M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$604.61K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$401.92K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$613.53K	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$1.16M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$801.57K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.47M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$23.59M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.10M	USD	3 Qtrs
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.71M	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.92M	USD	3 Qtrs
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-687.94K	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.28M	USD	3 Qtrs
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	`NetIncomeLossAvailableToCommonStockholdersBasic`	$182.94K	USD	3 Qtrs
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	`NetIncomeLossAvailableToCommonStockholdersBasic`	$3.15M	USD	1 Quarter
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	`NetIncomeLossAvailableToCommonStockholdersBasic`	$26.52M	USD	3 Qtrs
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	`NetIncomeLossAvailableToCommonStockholdersBasic`	$3.51M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$171.85K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$69.19K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$252.85K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$248.28K	USD	1 Quarter
Total comprehensive gain	`ComprehensiveIncomeNetOfTax`	$26.77M	USD	3 Qtrs
Total comprehensive gain	`ComprehensiveIncomeNetOfTax`	$354.78K	USD	3 Qtrs
Total comprehensive gain	`ComprehensiveIncomeNetOfTax`	$3.40M	USD	1 Quarter
Total comprehensive gain	`ComprehensiveIncomeNetOfTax`	$3.58M	USD	1 Quarter
Net income per share attributable to DocGo Inc. and Subsidiaries - Basic (in Dollars per share)	`EarningsPerShareBasic`	$0.06	USD	1 Quarter
Net income per share attributable to DocGo Inc. and Subsidiaries - Basic (in Dollars per share)	`EarningsPerShareBasic`	-	USD	3 Qtrs
Net income per share attributable to DocGo Inc. and Subsidiaries - Basic (in Dollars per share)	`EarningsPerShareBasic`	$0.03	USD	1 Quarter
Net income per share attributable to DocGo Inc. and Subsidiaries - Basic (in Dollars per share)	`EarningsPerShareBasic`	$0.26	USD	3 Qtrs
Weighted-average shares outstanding - Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	58.39M	shares	1 Quarter
Weighted-average shares outstanding - Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	98.96M	shares	1 Quarter
Weighted-average shares outstanding - Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	58.39M	shares	3 Qtrs
Weighted-average shares outstanding - Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	100.73M	shares	3 Qtrs
Net income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$0.04	USD	1 Quarter
Net income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$0.03	USD	1 Quarter
Net income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	3 Qtrs
Net income per share attributable to DocGo Inc. and Subsidiaries - Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$0.24	USD	3 Qtrs
Weighted-average shares outstanding - Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	109.17M	shares	3 Qtrs
Weighted-average shares outstanding - Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	107.40M	shares	1 Quarter
Weighted-average shares outstanding - Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	83.70M	shares	3 Qtrs
Weighted-average shares outstanding - Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	83.70M	shares	1 Quarter

Cash Flow Statement 101 line items

Line Item	Tag	Value	Unit	Period
Acquisition of remaining	`AcquisitionOfRemainings`	0.20	pure	3 Qtrs
Acquisition of remaining	`AcquisitionOfRemainings`	0.20	pure	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$801.57K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.47M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$23.59M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.10M	USD	3 Qtrs
Depreciation of property and equipment	`DepreciationNonproduction`	$1.70M	USD	3 Qtrs
Depreciation of property and equipment	`DepreciationNonproduction`	$2.59M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$2.27M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$990.35K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.43M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$553.00K	USD	1 Quarter
Amortization of finance lease right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$2.38M	USD	3 Qtrs
Amortization of finance lease right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$2.39M	USD	3 Qtrs
(Gain) Loss on disposal of assets	`GainLossOnSaleOfOtherAssets`	$-27.73K	USD	3 Qtrs
(Gain) Loss on disposal of assets	`GainLossOnSaleOfOtherAssets`	$42.67K	USD	3 Qtrs
Gain from PPP loan forgiveness	`GainsLossesOnRestructuringOfDebt`	$142.67K	USD	3 Qtrs
Gain from PPP loan forgiveness	`GainsLossesOnRestructuringOfDebt`	-	USD	3 Qtrs
Gain from equity method investment	`IncomeLossFromEquityMethodInvestments`	-	USD	3 Qtrs
Gain from equity method investment	`IncomeLossFromEquityMethodInvestments`	$99.84K	USD	3 Qtrs
Bad debt expense	`ProvisionForDoubtfulAccounts`	$2.15M	USD	3 Qtrs
Bad debt expense	`ProvisionForDoubtfulAccounts`	$2.70M	USD	3 Qtrs
Stock based compensation	`EmployeeBenefitsAndShareBasedCompensation`	$4.62M	USD	3 Qtrs
Stock based compensation	`EmployeeBenefitsAndShareBasedCompensation`	$1.22M	USD	3 Qtrs
Gain on remeasurement of finance leases	`GainLossOnTerminationOfLease`	-	USD	3 Qtrs
Gain on remeasurement of finance leases	`GainLossOnTerminationOfLease`	$1.39M	USD	3 Qtrs
Gain on remeasurement of warrant liabilities	`UnrealizedGainLossOnDerivatives`	$1.14M	USD	3 Qtrs
Gain on remeasurement of warrant liabilities	`UnrealizedGainLossOnDerivatives`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.89M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$28.79M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.53M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$282.67K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.79M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-882.43K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$9.42M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.98M	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.60M	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$24.86M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.85M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$37.61M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.99M	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.82M	USD	3 Qtrs
Acquisition of intangibles	`PaymentsToAcquireIntangibleAssets`	$1.57M	USD	3 Qtrs
Acquisition of intangibles	`PaymentsToAcquireIntangibleAssets`	$1.96M	USD	3 Qtrs
Acquisition of businesses	`OtherPaymentsToAcquireBusinesses`	$56.50K	USD	3 Qtrs
Acquisition of businesses	`OtherPaymentsToAcquireBusinesses`	$33.84M	USD	3 Qtrs
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$6.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.45M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-37.79M	USD	3 Qtrs
Proceeds from revolving credit line	`ProceedsFromLinesOfCredit`	$1.00M	USD	3 Qtrs
Proceeds from revolving credit line	`ProceedsFromLinesOfCredit`	$8.00M	USD	3 Qtrs
Repayments of notes payable	`RepaymentsOfNotesPayable`	$585.71K	USD	3 Qtrs
Repayments of notes payable	`RepaymentsOfNotesPayable`	$374.46K	USD	3 Qtrs
Due to seller	`DueToSeller`	-	USD	3 Qtrs
Due to seller	`DueToSeller`	$1.01M	USD	3 Qtrs
Noncontrolling interest contributions	`ProceedsFromMinorityShareholders`	$2.06M	USD	3 Qtrs
Noncontrolling interest contributions	`ProceedsFromMinorityShareholders`	$333.02K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromIssuanceOfCommonStock`	$1.88M	USD	3 Qtrs
Common stock repurchased	`PaymentsForRepurchaseOfCommonStock`	$497.76K	USD	3 Qtrs
Common stock repurchased	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Equity costs	`PaymentsOfStockIssuanceCosts`	-	USD	3 Qtrs
Equity costs	`PaymentsOfStockIssuanceCosts`	$19.57K	USD	3 Qtrs
Payments on obligations under finance lease	`PaymentsOfFinancingCosts`	$2.15M	USD	3 Qtrs
Payments on obligations under finance lease	`PaymentsOfFinancingCosts`	$1.83M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.13M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$685.87K	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$171.85K	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-252.85K	USD	3 Qtrs
Net increase in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$246.59K	USD	3 Qtrs
Net increase in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.71M	USD	3 Qtrs
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$43.16M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$179.35M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$179.11M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.46M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$43.16M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$179.35M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$179.11M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.46M	USD	Point-in-time
Cash paid for interest	`CashPaidForInterest`	$39.64K	USD	3 Qtrs
Cash paid for interest	`CashPaidForInterest`	$102.20K	USD	3 Qtrs
Cash paid for interest on finance lease liabilities	`CashPaidForInterestOnFinanceLeaseLiabilities`	$381.94K	USD	3 Qtrs
Cash paid for interest on finance lease liabilities	`CashPaidForInterestOnFinanceLeaseLiabilities`	$434.58K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	$613.53K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	$917.45K	USD	3 Qtrs
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$3.57M	USD	3 Qtrs
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$4.09M	USD	3 Qtrs
Fixed assets acquired in exchange for notes payable	`StockIssuedDuringPeriodValueAcquisitions`	-	USD	1 Quarter
Fixed assets acquired in exchange for notes payable	`StockIssuedDuringPeriodValueAcquisitions`	$271.19K	USD	3 Qtrs
Fixed assets acquired in exchange for notes payable	`StockIssuedDuringPeriodValueAcquisitions`	$819.23K	USD	3 Qtrs
Acquisition of remaining 20% of Ambulnz UK LTD	`StockIssued1`	-	USD	3 Qtrs
Acquisition of remaining 20% of Ambulnz UK LTD	`StockIssued1`	$228.52K	USD	3 Qtrs
Gain from PPP loan forgiveness	`GainFromPPPLoanForgiveness`	$142.67K	USD	3 Qtrs
Gain from PPP loan forgiveness	`GainFromPPPLoanForgiveness`	-	USD	3 Qtrs
Cash	`ReconciliationOfCash`	$169.60M	USD	3 Qtrs
Cash	`ReconciliationOfCash`	$39.55M	USD	3 Qtrs
Restricted Cash	`ReconcillationOfRestrictedCash`	$3.61M	USD	3 Qtrs
Restricted Cash	`ReconcillationOfRestrictedCash`	$9.75M	USD	3 Qtrs
Total cash and restricted cash shown in statement of cash flows	`TotalCashAndRestrictedCashShownInStatementOfCashFlows`	$43.16M	USD	3 Qtrs
Total cash and restricted cash shown in statement of cash flows	`TotalCashAndRestrictedCashShownInStatementOfCashFlows`	$179.35M	USD	3 Qtrs

Stockholders Equity 62 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$240.26M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$270.83M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$254.39M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.25M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$67.06M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.69M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.95M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$227.06M	USD	Point-in-time
Common stock repurchased	`StockRepurchasedDuringPeriodValue`	-	USD	1 Quarter
Common stock repurchased	`StockRepurchasedDuringPeriodValue`	$497.90K	USD	1 Quarter
Cashless exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-319.00	USD	1 Quarter
Cashless exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.64M	shares	3 Qtrs
UK Ltd. Restricted Stock	`StockIssuedDuringPeriodValueUKLtdRestrictedStock`	$82.31K	USD	1 Quarter
UK Ltd. Restricted Stock	`StockIssuedDuringPeriodValueUKLtdRestrictedStock`	$95.54K	USD	1 Quarter
Share warrants conversion	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$12.38M	USD	1 Quarter
Acquisitions	`StockIssuedDuringPeriodValueAcquisitions`	-	USD	1 Quarter
Acquisitions	`StockIssuedDuringPeriodValueAcquisitions`	$271.19K	USD	3 Qtrs
Acquisitions	`StockIssuedDuringPeriodValueAcquisitions`	$819.23K	USD	3 Qtrs
Effect of reverse acquisition	`StockIssuedDuringPeriodValueOther`	-	USD	1 Quarter
Conversion of share due to merger recapitalization	`StockIssuedDuringPeriodValueConversionOfUnits`	$7.65K	USD	1 Quarter
Effect of reverse acquisition	`StockIssuedEffectOfReverseAcquisition`	$66.95M	USD	1 Quarter
Share issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$17.00	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueExerciseOfStockOptions`	$779.07K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueExerciseOfStockOptions`	$374.34K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueExerciseOfStockOptions`	$728.50K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.00M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$391.53K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$463.05K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$370.00K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.42M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.02M	USD	1 Quarter
UK Ltd. Shares purchase	`StockIssuedDuringPeriodValueUKLtdSharesPurchase`	$-523.72K	USD	1 Quarter
Fees associated with equity raise	`StockIssuedDuringPeriodValueFeesAssociatedWithEquityRaise`	$-1.40K	USD	1 Quarter
Net income attributable to stockholders of Ambulnz, Inc. and Subsidiaries	`NetLossAttributableToStockholdersOfAmbulnzIncAndSubsidiaries`	$3.51M	USD	1 Quarter
Equity cost	`StockIssuedDuringPeriodValueEquityCost`	$-19.57K	USD	1 Quarter
Noncontrolling interest contribution	`NoncontrollingInterestContribution`	$2.06M	USD	1 Quarter
Noncontrolling interest contribution	`NoncontrollingInterestContribution`	$333.02K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$10.43K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$94.66K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$69.19K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-248.28K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$8.00K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.86K	USD	1 Quarter
Net income (loss) attributable to Noncontrolling interests	`ProfitLoss`	$1.75M	USD	1 Quarter
Net income (loss) attributable to Noncontrolling interests	`ProfitLoss`	$-687.94K	USD	1 Quarter
Net income (loss) attributable to Noncontrolling interests	`ProfitLoss`	$-1.26M	USD	1 Quarter
Net income (loss) attributable to Noncontrolling interests	`ProfitLoss`	$-979.79K	USD	1 Quarter
Net income (loss) attributable to Noncontrolling interests	`ProfitLoss`	$-320.63K	USD	1 Quarter
Net income (loss) attributable to Noncontrolling interests	`ProfitLoss`	$-2.71M	USD	1 Quarter
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-1.68M	USD	1 Quarter
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$10.63M	USD	1 Quarter
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-1.65M	USD	1 Quarter
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$3.15M	USD	1 Quarter
Net income (loss) attributable to stockholders of DocGo Inc. and Subsidiaries	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$12.74M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$240.26M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$270.83M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$254.39M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.25M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$67.06M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.69M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.95M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$227.06M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.